Skip to main content
. 2018 Jul 23;3(5):e000398. doi: 10.1136/esmoopen-2018-000398

Figure 4.

Figure 4

Summary of indications of targeted therapy according to the MTB decision (second row), highest level OnoKB recommendations for LB-detected alterations (third row) and highest level OncoKB recommendations for tumour tissue-detected alterations (fourth row). lbNGS, liquid biopsy NGS; MTB, molecular tumour board; NGS, next generation sequencing; ttNGS, tumour tissue NGS.